The need for human cornea equivalent tissues continues to grow with an estimated 10 million people worldwide suffering from corneal vision loss. There remain few clinical options today to meet these growing needs. In this renewal proposal we will build upon our progress in generating functional human cornea replacements. The hypothesis is that tissue engineered cornea systems based on mechanically robust, patterned, porous, thin optically clear silk protein films, in combination with appropriate cell types, can generate functional cornea tissue equivalents to meet these clinical needs. Our current data support the approaches planned and also allow for broader impact for these new cornea tissues systems for both in vivo clinical goals as well as for in vitro tissue equivalents fr drug screening. We plan to expand on our progress to date and generate multifunctional corneal tissue systems with tuned rates of tissue remodeling, innervation guidance, circumvention of suturing upon implantation and modulation of local infections and inflammation. Further, we plan to establish these corneal tissue systems to meet clinical needs as well as for in vitro substitute for drug screening.
The aims will address optimizing the structure and function of the lamellar biomaterial structures that form the basis of our cornea designs (focusing on remodeling rates, control of infections and inflammation, ad hoc cell substrate, and optimized co-culture methods to develop partial thickness equivalent tissues based on corneal stem cells, epithelial, and neuronal cells), in vitro studies for sustained tissue function to screen ocular drugs, as well as n vivo studies to asses clinical relevance in order to progress to full integration of the tissue equivalents, are planned. An interdisciplinary team of investigators that has been involved in the present proposal will pursue the new project goals in this renewal, including David Kaplan (silk biomaterials, tissue engineered cornea), James Funderburgh (corneal tissue biology, corneal stem cells), and Mark Rosenblatt (clinical, animal models).

Public Health Relevance

The answer to the growing need for corneal transplants is based mainly on two main approaches: allogenic and synthetic materials. Although allogenic materials originating from human donors are the preferred choice, there is a shortage in availability of quality-donor graft material, due to the increasing number of LASIK surgeries, which compromise the corneal stroma. In addition, tissue rejection limits the long-term success of this approach. Alternatively, synthetic keratoprostheses based on polymethylmethacrylate still require corneal tissue carriers and have myriad potential complications including corneal melting, uveitis, endophthamitis, and retinal detachment, resulting in high incidence of graft failure. Furthermore, increased interest in reducing animal testing for commercial products prompts the need for in vitro preclinical cornea tissue models.

National Institute of Health (NIH)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Mckie, George Ann
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Tufts University
Engineering (All Types)
Biomed Engr/Col Engr/Engr Sta
United States
Zip Code
Tokareva, Olena; Jacobsen, Matthew; Buehler, Markus et al. (2014) Structure-function-property-design interplay in biopolymers: spider silk. Acta Biomater 10:1612-26
Wu, Jian; Rnjak-Kovacina, Jelena; Du, Yiqin et al. (2014) Corneal stromal bioequivalents secreted on patterned silk substrates. Biomaterials 35:3744-55
Partlow, Benjamin P; Hanna, Craig W; Rnjak-Kovacina, Jelena et al. (2014) Highly tunable elastomeric silk biomaterials. Adv Funct Mater 24:4615-4624
Wang, Qin; Xia, Xiaoxia; Huang, Wenwen et al. (2014) High Throughput Screening of Dynamic Silk-Elastin-Like Protein Biomaterials. Adv Funct Mater 24:4303-4310
Tokareva, Olena; Michalczechen-Lacerda, Valquiria A; Rech, Elibio L et al. (2013) Recombinant DNA production of spider silk proteins. Microb Biotechnol 6:651-63
Zarbin, Marco A (2013) Accelerated in vitro degradation of optically clear low-? sheet silk films by enzyme-mediated pretreatment. JAMA Ophthalmol 131:676
Guziewicz, Nicholas A; Massetti, Andrew J; Perez-Ramirez, Bernardo J et al. (2013) Mechanisms of monoclonal antibody stabilization and release from silk biomaterials. Biomaterials 34:7766-75
Hu, Xiao; Park, Sang-Hyug; Gil, Eun Seok et al. (2011) The influence of elasticity and surface roughness on myogenic and osteogenic-differentiation of cells on silk-elastin biomaterials. Biomaterials 32:8979-89
Karve, Kiran A; Gil, Eun Seok; McCarthy, Stephen P et al. (2011) Effect of ?-sheet crystalline content on mass transfer in silk films. J Memb Sci 383:44-49
Xia, Xiao-Xia; Xu, Qiaobing; Hu, Xiao et al. (2011) Tunable self-assembly of genetically engineered silk--elastin-like protein polymers. Biomacromolecules 12:3844-50

Showing the most recent 10 out of 11 publications